ADC Therapeutics SA
ADCT
$3.10
-$0.01-0.32%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.01% | 17.17% | 63.86% | 5.90% | 25.30% |
| Total Depreciation and Amortization | 0.24% | -4.98% | -6.38% | -9.38% | 3.20% |
| Total Amortization of Deferred Charges | 47.73% | -62.03% | -180.26% | -37.00% | -34.62% |
| Total Other Non-Cash Items | 117.15% | -2.68% | -103.08% | 2.89% | -2.53% |
| Change in Net Operating Assets | 418.47% | -197.44% | 47.41% | 1,944.71% | -195.98% |
| Cash from Operations | 26.66% | -27.76% | 30.92% | 31.71% | 6.12% |
| Capital Expenditure | 100.00% | 50.28% | 72.48% | 67.32% | 97.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 50.28% | 72.48% | 67.32% | 97.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -4.73% | -23.88% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -116,200.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.98% | -23.88% | -111,900.00% | -351.86% | 35.01% |
| Foreign Exchange rate Adjustments | 1,258.33% | 474.42% | -325.66% | 346.61% | -80.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.11% | -26.75% | 26.42% | 30.34% | 78.11% |